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OBJECTIVES: To determine the incidence and correlates of
combined declines in cognitive and physical performance.
DESIGN: Cohort study of community-dwelling older
women with moderate to severe disability.
SETTING: The community surrounding Baltimore, Mary-
land.
PARTICIPANTS: Participants in the Women’s Health and
Aging Study I with Mini-Mental State Examination
(MMSE) score or 24 or greater and walking speed greater
than 0.4 m/s at baseline.
MEASUREMENTS: Cognitive decline was defined as an
MMSE score less than 24 and physical decline as a walking
speed of 0.4 m/s or less in at least one of the three annual
follow-up visits. Participants were stratified into groups
based on cognitive or physical decline or both. Group char-
acteristics were compared, and results were adjusted for
age, race, education, and significant covariates.
RESULTS: Of 558 women that met the baseline MMSE
and walking speed inclusion criteria, 21% developed phys-
ical decline, 12% developed cognitive decline, and 11%
experienced combined cognitive and physical decline. After
adjustment, physical decline was associated with age, non-
white race, former smoking, baseline walking speed, and
instrumental activities of daily living (IADL) impairment.
Cognitive decline was associated with age and baseline
MMSE score. Combined decline was associated with age,
baseline walking speed, MMSE score, IADL impairment, as
well as current smoking (odds ratio (OR)55.66, 95%
confidence interval (CI)51.49–21.54) and hemoglobin
level (OR50.68, 95% CI50.47–0.98).
CONCLUSION: Potential predictors of cognitive and
physical performance decline were identified. The associa-
tion between smoking and lower hemoglobin levels and
combined cognitive and physical decline may represent po-
tentially modifiable risk factors and should be confirmed in
future studies. J Am Geriatr Soc 53:1197–1202, 2005.
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Cognitive and physical decline are important to the de-velopment of disability in older adults. Instrumental
activities of daily living (IADLs) explicitly include physical
and cognitive elements.1 Activities of daily living (ADLs) are
understood to be physical capabilities but are also affected
by cognitive impairment.2 Clinical and research findings
have demonstrated that a variety of diseases affecting cog-
nition are associated with deteriorating physical function.3–7
Classification and assessment of the severity of cognitive
impairment often depends on physical function status.8
However, research for preventing disability in older adults
has more often examined decline in the cognitive or physical
domains individually. Identification of factors for combined
cognitive and physical decline could point to targets for po-
tential interventions, including risk factor modification or
more aggressive treatment of comorbidities.
The use of self-reported physical function has generally
limited prior studies examining the relationship between
cognitive and physical function. It is likely that cognitive
decline affects the self-perception of physical function.9
Measures of physical performance, such as walking speed,
have been demonstrated to predict functional dependence
in persons with and without cognitive impairment.10,11
Such measures may be more reliable and provide additional
information on the process of combined cognitive and
physical decline. Combined declines in physical and cogni-
tive performance have been demonstrated in a high-func-
tioning older population,12 but these findings have never
been extended to individuals with lower functional status.
Further understanding of the interrelationship between
cognitive and physical function is needed in frail popula-
tions because these individuals are at highest risk for func-
tional dependence and major health-related events.13
Additionally, frail individuals have more comorbid condi-
tions than higher-functioning individuals, thus providing a
greater number of potential predictors of decline to assess.
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The aim of the present study was to characterize com-
bined declines in cognitive and physical performance in a
lower-functioning population and to identify specific fac-
tors associated with this pattern of decline versus physical
decline alone, cognitive decline alone, or no decline. The
Women’s Health and Aging Study (WHAS) I was a 3-year
prospective study of older women established to study the
course and causes of disability in moderate to severely dis-
abled women and is therefore well suited for addressing
these associations.
METHODS AND PARTICIPANTS
The WHAS I Population
The WHAS I was a prospective study of disability in 1,002
older women residing in the community surrounding Bal-
timore, Maryland. The design and characteristics of the
cohort are described in more detail elsewhere.14 Briefly,
women with moderate to severe disability were enrolled
and followed over 3 years with in-home study assessments
by trained study nurses every 6 months. Basic inclusion
criteria for the WHAS study consisted of having self-report
difficulty in performing tasks in two or more of the follow-
ing areas: basic self-care, higher-functioning tasks of daily
living, upper extremity activities, and mobility. The re-
search ethics committee of Johns Hopkins University
approved WHAS I, and participants provided written in-
formed consent upon enrollment.
For the present analyses, 558 participants with a Mini-
Mental State Examination (MMSE)15 score of 24 or greater
and walking speed greater than 0.4 m/s at baseline were
considered. Selected participants had at least one follow-up
visit. A total of 367 participants did not meet inclusion
MMSE and walking speed criteria. Additionally, 77 partic-
ipants were excluded because data were not available be-
yond the baseline visit. Of those participants, 20 died
during the first year, and of the remaining 57 participants,
the most common reason for unavailability of data was
refusal to participate in the interview and examination.
Cognitive and Physical Decline Measures
Cognition was assessed using the Folstein MMSE.15 Cog-
nitive decline was defined as a decrease in MMSE to less
than 24, a generally accepted cutoff for abnormal cogni-
tion16 recorded in at least one of the three annual follow-up
visits.
Walking speed was calculated as the time to walk 4 m
at usual pace. In fewer than 10% of the participants, a
distance of 3 m was used because of space limitations in the
home. Physical decline was defined as a decrease in walking
speed to less than 0.4 m/s in at least one of the three annual
follow-up visits. A walking speed lower than 0.42 m/s
has been demonstrated to be predictive of functional de-
pendence and is considered to represent severe walking
disability.17,18
Participants were classified into four main groups ac-
cording to changes in cognitive and physical performance
over the three annual follow-up visits: no cognitive or
physical decline, physical decline only, cognitive decline
only, and combined cognitive and physical decline.
Covariates
The four groups were compared on the basis of sociode-
mographic characteristics and health habits (age, race, ed-
ucation, marital status, and smoking status), cognitive,
affective, and functional measures (MMSE score, Geriatric
Depression Scale (GDS) score,19 ADL2 and IADL1 impair-
ment, and walking speed), diseases (discussed below),
and biological risk measures (body mass index, ankle
brachial index (ABI), total cholesterol, high-density lipo-
protein cholesterol, serum creatinine, hemoglobin level,
and spirometry).
Sociodemographic characteristics and health habits
were self-reported. Educational level was dichotomized
as 8th grade or less or more than 8th grade, and current
marital status was reported as married or not married.
The number of ADLs and IADLs in which participants re-
ported requiring assistance defined ADL and IADL disabil-
ity. ADLs were transferring, bathing, using the toilet,
dressing, and feeding oneself.2 IADLs were shopping,
doing light housework, preparing meals, managing
money, using the telephone, and self-administering
medications.1
The methods of disease ascertainment in WHAS have
been extensively described elsewhere.20 Briefly, the status of
17 chronic conditions were assessed on the basis of self-
report, medical records, examinations, roentgenograms,
medications, laboratory testing, and questionnaires sent to
primary physicians. The presence of each disease was as-
certained through application of data to standardized al-
gorithms that were reviewed by trained clinicians. For these
analyses, the total number of diseases and presence of eight
diseases with strong relevance to cognitive or physical
function were considered: coronary artery disease, periph-
eral arterial disease, congestive heart failure, stroke, diabe-
tes mellitus, cancer, osteoarthritis, and pulmonary disease.
Coronary artery disease, peripheral arterial disease, con-
gestive heart failure, and stroke were combined into a single
variable: cardiovascular disease. Only diseases classified as
definite were included.
Biological risk measures were determined through
physical assessments and laboratory work done at base-
line. Body mass index was calculated as weight in kg di-
vided by height in meters squared. Weight was measured on
a calibrated digital scale placed on a firm surface with the
participant standing wearing light house clothes and no
shoes, and height was measured using a stadiometer. ABI
was measured using a Doppler stethoscope (Parks model
841-A, Aloha, OR). Two blood pressures were assessed in
the right brachial artery and in each of the posterior tibial
arteries. The higher of the two pressures in each artery was
used, and the ABI was calculated by dividing the lower of
the right and left posterior tibial pressures by the brachial
artery pressure. Total cholesterol, high-density lipoprotein
cholesterol, serum creatinine concentrations (all in mg/dL),
and hemoglobin level (in g/dL) were measured using stand-
ard methods. Spirometry measures include forced expira-
tory volume in the first second (FEV1) and forced vital
capacity (FVC), measured according to a standard proto-
col.21,22 Results are reported for FEV1 less than 80% of
predicted value and calculated FEV1/FVC ratio of less than
70% of predicted value for each participant.22
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Statistical Methods
The relationship between cognitive and physical decline
was tested for independence using a Pearson chi-square test.
Physical and cognitive decline groups were compared using
chi-square and analysis of variance tests for categorical and
continuous variables, respectively. Three separate logistic
regression analyses were performed comparing the physi-
cal, cognitive, and combined decline groups with the group
with neither decline. Models were adjusted for age, race,
education, and all covariates found using univariate anal-
ysis to be statistically significant (Po.05) to provide odds
ratios (ORs) and 95% confidence intervals (CIs). SPSS ver-
sion 10.1 software was used (SPSS Corp., Chicago, IL).
RESULTS
Women participating in WHAS I had a mean age of
78.0  8.1 at baseline; 71% were white, and 43% had an
8th grade education or less. The mean MMSE score was
26.0  3.0, and the mean number of IADLs and ADLs im-
paired were 1.3  1.4 and 1.2  1.4, respectively.
Of the 558 women who met the baseline MMSE and
walking speed inclusion criteria, 318 (57%) developed no
decline, 112 (21%) developed physical decline only, 68
(12%) developed cognitive decline only, and 60 (11%) ex-
perienced combined cognitive and physical decline. From
the assessment of statistical independence of cognitive and
physical decline, physical decliners were 1.98 times
(Po.001) as likely to have cognitive decline as nonphysi-
cal decliners, and cognitive decliners were 1.80 times
(Po.001) as likely to develop physical decline.
The timing and magnitude of declines below the cutoff
levels for MMSE and walking speed were assessed. In in-
dividuals with cognitive decline (n5128), a drop below the
cutoff MMSE of 24 occurred in 8% at Year 1, 27% at Year
2, and 65% at Year 3. In those with physical decline
(n5172), a drop below the cutoff walking speed of 0.4 m/s
occurred in 6% at Year 1, 18% at Year 2, and 76% at
Year 3.
Comparing the 128 subjects who developed cognitive
decline with the 430 not developing cognitive decline, more
participants with cognitive decline had a baseline MMSE
score of 24 or 25 (35% vs 10%), but participants devel-
oping cognitive decline showed significantly greater losses
from baseline in MMSE points than did those without cog-
nitive decline (Year 1: 2.5 vs  0.1; Year 2: 3.5 vs  0.1;
Year 3:  4.6 vs  0.4, all Po.001).
Comparing the 172 subjects developing physical de-
cline with the 386 not developing physical decline, more
participants with physical decline had a baseline walking
speed below 0.6 m/s (48% vs 17%). Participants developing
physical decline had significantly greater losses in walking
speed (in m/s) from baseline than those without physical
decline (Year 1:  0.20 vs 0.03; Year 2: 0.33 vs  0.04;
Year 3: 0.53 vs  0.05; all Po.001).
Characteristics of the groups of women with no de-
cline, cognitive decline alone, physical decline alone, or
combined decline were compared. Results are reported in
Table 1. Women with physical, cognitive, or combined de-
cline were more likely to be older and less likely to be mar-
ried than those with no decline. Subjects with cognitive
decline alone had a lower educational level, less pulmonary
disease, and lower baseline MMSE scores than those with
no decline or physical decline only. Subjects with cognitive
decline alone had fewer diseases and a higher baseline
walking speed than those with physical decline only. Ad-
ditionally, women with cognitive decline only had less im-
pairment in ADLs than those with no decline, physical
decline only, or combined decline. Subjects with physical
decline only and combined decline were more likely to have
higher GDS scores than those with no decline.
In these unadjusted comparisons, women with com-
bined decline were less likely to be white than those with no
decline or physical decline only. Additionally, those with
combined decline had a lower educational level, hemoglo-
bin level, and mean baseline MMSE score than women with
no decline or physical decline only. Participants with com-
bined decline had lower baseline walking speed and more
baseline impairments in IADLs than those with no decline
or cognitive decline only. Participants with combined de-
cline were also more likely to smoke than those with cog-
nitive decline only.
Table 2 shows ORs and 95% CIs from three separate
logistic regression models in which the reference group of
participants with neither cognitive nor physical decline
were compared with the groups with physical decline only,
cognitive decline only, and combined decline. The models
were adjusted for age, race, education, and covariates found
to be statistically significant at the univariate analyses
(smoking, education, number of diseases, pulmonary dis-
ease, hemoglobin, baseline walking speed, baseline MMSE,
baseline IADL, baseline ADL). Age was significantly asso-
ciated with all patterns of decline. Former smoking status
was significantly associated with physical decline only, and
white race was inversely associated with physical decline.
Lower baseline walking speed and greater IADL impair-
ment was associated with physical decline only and com-
bined decline. Lower baseline MMSE was associated with
cognitive decline and combined decline.
Current smoking (OR55.66, 95% CI51.49–21.54)
and hemoglobin level (OR50.68, 95% CI5 0.47–0.98)
were the strongest predictors of combined decline that were
not also statistically significantly associated with isolated
declines in physical or cognitive performance.
DISCUSSION
In this population of lower-functioning women, the occur-
rence of combined declines in cognition and physical per-
formance was greater than expected based on the
proportion of the cohort declining in either domain con-
sidered separately. This finding suggests that declines in the
two domains may share underlying etiologies. This study
also identified significant demographic, functional, health,
and biological differences in women with combined cogni-
tive and physical decline.
Several studies link cognitive and physical function, but
all are limited in important ways in addressing combined
cognitive and physical decline. Selection bias, prevalence/
incidence bias, and bias due to selective survival limit cross-
sectional studies.3 Longitudinal studies have confirmed that
baseline cognitive status and cognitive decline predict sub-
sequent physical function status,4–7 but they do not provide
substantial insight into factors contributing to combined
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changes in cognition and physical function. The use of self-
or proxy-reported information on physical function, which
may be less reliable as individuals decline cognitively, also
limit them.9 The current study of lower-functioning women
extends the findings of a recent longitudinal study of high-
functioning, disability-free older adults in which objective
physical performance declines were mapped to declines in
global cognition over a 7-year follow-up.12
Of the differences noted in this study in patterns of
decline, current tobacco smoking and lower hemoglobin
levels appear to be uniquely associated with combined de-
clines even after adjustment for potential confounders. It is
possible that these factors are simply indicators of persons
who are globally less healthy, but the observations are also
consistent with current knowledge about the individual as-
sociations between smoking, anemia, and cognitive and
physical status. Smoking has been shown to be associated
with accelerated cognitive decline in a large cohort of non-
demented elderly subjects.23 In addition, smoking and sa-
rcopenia were found to be related in two recent studies.24,25
Chronic anemia has been demonstrated to be associated
with declines in cognitive functioning in cancer patients,26
and there is growing interest in the potential effects of an-
emia on cognitive performance in older people. Hemoglo-
bin levels and anemia also appear to be related to muscle
strength, muscle density, physical performance, and disa-
bility independent of disease status or inflammation.27,28 In
addition to these potential separate effects on the nervous
system and muscles, it may also be that smoking (via effects
on atherosclerosis and oxygenation) and lower hemoglobin
Table 1. Baseline Characteristics of Participants Who Developed Cognitive, Physical, or Combined Decline During the
Follow-Up (Mean, or %)
Characteristic
No Decline Physical Decline Cognitive Decline Combined Decline
(n5 218) (n5 112) (n5 68) (n5 60)
Age, mean  SD 74.4  6.4wz§ 78.5  7.6 78.9  7.7 79.4  8.7
White, % 82.7§ 78.6§ 72.1 61.7w
Smoking, %
Never 52.5§ 48.2 50.0§ 40.0z
Former 35.8z 40.2 44.1§ 38.3z
Current 11.6 11.6 5.9§ 21.7z
Education, %
8th grade 28.6z§ 25.9z§ 55.9w 56.7w
48th grade 71.4z§ 74.1z§ 44.1w 43.3w
Marital status, %
Married 34.3wz§ 16.1 14.7 8.3
Not married 65.7wz§ 83.9 85.3 91.7
Geriatric Depression Scale score,
mean  SD
6.7  4.9w§ 7.8  5.9 7.2  4.7 8.0  5.1
Number of diseases, mean  SD 2.9  1.5 3.2  1.8z 2.5  1.7w 2.8  1.8
Cardiovascular disease, % 43.4 53.6 42.6 46.7
Cancer, % 14.5 14.3 8.8 8.3
Diabetes mellitus, % 12.9 17.9 10.3 15.0
Osteoarthritis, % 80.8 80.4 70.6 75.0
Pulmonary disease, % 32.1z 33.9z 14.7w 28.3
Body mass index, kg/m2, mean  SD 28.8  6.2 29.2  7.4 28.3  5.5 29.5  8.4
Ankle brachial index, mean  SD 1.1  0.2 1.1  0.2 1.1  0.2 1.0  0.2
Albumin, mg/dL, mean  SD 4.1  0.3 4.0  0.3 4.0  0.2 4.0  0.5
Total cholesterol, mg/dL, mean  SD 227.8  40.2 224.8  43.7 225.5  37.6 222.8  36.5
High-density lipoprotein cholesterol, mg/dL,
mean  SD
54.7  15.5 52.2  14.7 51.9  15.5 49.5  14.6
Creatinine, mg/dL, mean  SD 1.0  0.3 1.1  0.4 1.1  0.2 1.3  1.5
Hemoglobin, g/dL, mean  SD 13.3  1.2§ 13.0  1.5§ 12.8  1.1 12.3  1.4w
FEV1 o80% predicted, % 44.1 48.6 40.4 45.0
FEV1/forced vital capacityo70% predicted, % 43.2 40.0 23.4 42.5
Baseline Mini-Mental State Examination score,
mean  SD
28.1  1.6z§ 27.8  1.7z§ 26.5  1.9w 26.6  1.7w
Baseline walking speed, m/s, mean  SD 0.83  0.25w§ 0.68  0.25z 0.75  0.16w§ 0.62  0.15z
Baseline instrumental activities of daily living,
mean  SDk
0.5  0.8w§ 1.1  1.1z 0.6  0.7w§ 1.5  1.1wz
Baseline activities of daily living, mean  SDk 1.0  1.1z 1.2  1.2z 0.8  1.0w§ 1.1  1.2z
Physical decline was defined as walking speed falling to 0.4 m/s or less and cognitive decline as Mini-Mental State Examination (MMSE) score falling to less than 24
in one of the three annual follow-up visits.
Po.05 compared with the group with no decline; wphysical decline; z cognitive decline; § combined decline.
kHigher values indicate greater impairment.
SD5 standard deviation; FEV15 forced expiratory volume in 1 second.
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concentrations (via decreased oxygen delivery) affect
specific central nervous system processes associated
with cognition and motor performance (frontal-subcorti-
cal circuits).29
The main strengths of this study are its use of data
collected specifically for the purpose of understanding dis-
eases and conditions contributing to disability in high-risk
older women. Characterizing combined cognitive and phys-
ical decline in this group is particularly pertinent because it
may lead to better understanding of the process of decline in
the population most at risk for functional dependence.13
This study also uses a performance-based measure of phys-
ical function to characterize physical decline. This approach
offers distinct advantages over the use of self- or proxy-
reports of disability to characterize decline, including in-
creased sensitivity to change and less-explicit influence of
language, culture, education, and cognition.9
There are also several limitations of this study. The di-
chotomization of outcomes to create groups with and with-
out decline and the modest sample sizes of each declining
group likely limited power to detect true differences. De-
spite these limitations, it was possible to detect significant
predictors for the outcome variables that could be more
deeply explored in specifically designed studies. It is also
possible that some of the findings (e.g., the association be-
tween smoking and lower hemoglobin levels and combined
decline) could be due to chance, a potential pitfall of mul-
tiple comparisons. Nonetheless, the findings seem consist-
ent with other reports focusing on cognitive and physical
function separately. Another limitation of the present study
is the use of the MMSE, because it is not a sensitive means of
detecting subtle declines in cognitive function in commu-
nity-dwelling, cognitively intact persons.30 Similarly, the
definition of physical decline as falling to below a specific
cutoff may have limited the detection of more subtle de-
clines in physical performance. Another concern is that a
substantial proportion of subjects with cognitive decline,
physical decline, or combined decline were already close to
the cutoff levels defining decline at baseline. However the
assessment of the magnitude of decline indicated that in-
dividuals declining cognitively or physically had indeed de-
clined to a significantly greater degree than those not
declining. Although the definitions of cognitive and phys-
ical performance decline were chosen to be most sensitive to
changes in status with the small sample size, some individ-
uals who declined to below the cutoff points at any follow-
up visit may have improved in performance at subsequent
follow-up visits. However, as indicated by the assessment of
the timing of decline, the majority of declines below cutoff
levels occurred at the third follow-up visit. Additionally, by
the design of these analyses, no direction of causality can be
determined to explain combined cognitive and physical de-
cline, and future studies are needed to examine this ques-
tion. Finally, due to the nature of the sample, these findings
are limited to older functionally impaired women.
In summary, these findings add support to an emerging
body of evidence for the link between age-related cognitive
and physical decline. The results also show that there are
specific pathological associations with combined decline. Ev-
idence that certain factors (tobacco smoking and lower hem-
oglobin levels) may be specific discriminators of individuals
at risk for combined cognitive and physical decline may pro-
vide a basis for developing approaches to prevent or reduce
disability in and institutionalization of these individuals.
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Table 2. Logistic Regression Models Assessing the Association Between Baseline Characteristics and Cognitive Decline
Only, Physical Decline Only, or Combined Decline
Characteristic
Physical Decline Cognitive Decline Combined Decline
(n5 112) (n5 68) (n5 60)
Odds Ratio (95% Confidence Interval)
Age 1.10 (1.05–1.16) 1.09 (1.03–1.16) 1.07 (1.00–1.15)
White 0.40 (0.19–0.86) 1.00 (0.37–2.71) 0.55 (0.19–1.56)
Smoking
Never 1 1 1
Former 1.97 (1.02–3.80) 1.03 (0.43–2.46) 1.38 (0.48–4.00)
Current 2.16 (0.76–6.13) 1.19 (0.31–4.54) 5.66 (1.49–21.54)
Education (8th grade) 0.55 (0.27–1.15) 1.38 (0.60–3.19) 0.97 (0.36–2.57)
Number of diseases 1.17 (0.97–1.41) 0.94 (0.72–1.23) 0.75 (0.53–1.05)
Pulmonary disease 0.95 (0.49–1.83) 0.49 (0.17–1.33) 1.96 (0.69–5.56)
Hemoglobin, g/dL 0.97 (0.77–1.23) 0.86 (0.60–1.21) 0.68 (0.47–0.98)
Baseline walking speed (per SD increasew) 0.70 (0.48–1.00) 0.99 (0.64–1.54) 0.46 (0.22–0.97)
Baseline Mini-Mental State Examination score 1.02 (0.85–1.23) 0.56 (0.44–0.70) 0.70 (0.54–0.92)
Baseline instrumental activities of daily living 2.04 (1.46–2.86) 1.40 (0.86–2.29) 2.58 (1.58–4.20)
Baseline activities of daily living 0.86 (0.65–1.12) 0.79 (0.55–1.12) 0.80 (0.53–1.20)
Note: Reference group: No physical or cognitive decline (n5 318). Analysis was performed using separate logistic regression models adjusted for age, race, smoking,
education, number of diseases, pulmonary disease, hemoglobin, baseline walking speed, baseline Mini-Mental State Examination score, baseline instrumental
activities of daily living, and baseline activities of daily living.
wBaseline walking speed standard deviation (SD)50.24 m/s.
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